Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir-Reference-Cited by-同舟云学术

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir

Published:2021-06-14 Issue:4 Volume:10 Page:2203-2222
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Aghemo Alessio,Horsmans Yves,Bourgeois Stefan,Bondin Mark,Gschwantler Michael,Hofer Harald,Semmo Nasser,Negro Francesco,Zhang Zhenzhen,Marcinak John,Veitsman Ella,Hazzan Rawi,Mimidis Konstantinos,Goulis Ioannis,Marques Nuno,Flisiak Robert,Mazur Wlodzimierz,Roncero Carlos,Marra Fiona,Pageaux Georges Philippe,Asselah Tarik,Lampertico Pietro

Funder

AbbVie Inc

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00455-1.pdf

Reference57 articles.

1. Asselah T, Marcellin P, Schinazi RF. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure? Liver Int. 2018;38(suppl 1):7–13.

2. Li G, De Clercq E. Current therapy for chronic hepatitis C: the role of direct-acting antivirals. Antiviral Res. 2017;142:83–122.

3. WHO. Global hepatitis report, 2017. World Health Organization. 2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf. Accessed 10 Feb 2021.

4. WHO. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, July 2018. 2018. https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2018/en/. Accessed 10 Feb 2021.

5. Dore GJ, Trooskin S. People with hepatitis C who inject drugs—underserved, not undeserving. N Engl J Med. 2020;383(7):608–11.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfil clínico de los pacientes españoles con hepatitis C naïve con cirrosis compensada tratados en el estudio CREST;Gastroenterología y Hepatología;2024-06

2. Clinical profile of Spanish hepatitis C virus-infected treatment-naïve patients with compensated cirrhosis in the CREST study;Gastroenterología y Hepatología (English Edition);2024-06

3. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study;Hepatology;2024-05-20

4. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan;Infectious Diseases and Therapy;2024-04-28

5. Adherence in Hepatitis C Virus Treatment: What We Know;Seminars in Liver Disease;2024-04-24